Ionis Pharmaceuticals, Inc. (IONS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Ionis Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -33.22x | -11.52x | -19.75x | -19.86x | -150.06x | -17.77x |
| P/B Ratio | 25.88x | 8.88x | 18.71x | 9.35x | 5.56x | 10.62x |
| P/S Ratio | 13.41x | 7.41x | 9.18x | 9.12x | 5.29x | 10.82x |
| Profitability | ||||||
| Gross Margin | 98.3% | 98.4% | 98.8% | 97.6% | 98.7% | 98.4% |
| Operating Margin | -40.5% | -67.4% | -44.9% | -69.8% | -3.7% | -23.6% |
| Net Margin | -40.4% | -64.4% | -46.5% | -45.9% | -3.5% | -60.9% |
| EBITDA Margin | -30.4% | -50.2% | -29.9% | -38.8% | -0.6% | -15.2% |
| Liquidity | ||||||
| Current Ratio | 3.83x | 8.47x | 5.90x | 7.07x | 9.75x | 3.56x |
| Quick Ratio | 3.81x | 8.43x | 5.88x | 7.00x | 9.65x | 3.52x |
| Leverage | ||||||
| Debt/Equity | 5.35x | 2.41x | 3.76x | 2.39x | 1.62x | 1.22x |
YoY = year-over-year change. Source: FMP..